Results 211 to 220 of about 2,710,187 (284)

Laser for genitourinary syndrome of menopause: what we know and what we need to know

Fiona Li, Jason Abbott
openalex   +1 more source

Vaginal carbon dioxide laser therapy and tropocollagen injections – combination therapy of the genitourinary syndrome of menopause

Andrzej Woźniak
openalex   +1 more source

Clinical Effect of Hibiscus taiwanensis Extract on Women with Genitourinary Syndrome of Menopause

Cheng‐Yu Long, Kun‐Ling Lin, Jwu‐Lai Yeh, Chien‐Wei Feng, Zi-Xi Loo   +4 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Genitourinary Syndrome of Menopause

Journal of Midwifery & Women's Health, 2021
AbstractGenitourinary syndrome of menopause (GSM) occurs in approximately 50% of menopausal women but is both underrecognized and undertreated despite numerous treatment options. Vaginal dryness, irritation, dyspareunia, urinary frequency, and urinary urgency are some of the more common symptoms that can have a negative effect on women's lives and ...
Ginny Moore, Queen Henry-Okafor, Erin DeBruyn, Melissa Ott   +3 more
openaire   +4 more sources

The genitourinary syndrome of menopause

Menopause, 2021
Abstract Genitourinary syndrome of menopause (GSM) refers to a collection of symptoms resulting from diminished hormonal, primarily estrogenic stimulation to the vulvovaginal or lower urinary tract and may affect up to 50% of postmenopausal women.
Nancy Phillips, Gloria Bachmann
openaire   +3 more sources

Genitourinary Syndrome of Menopause

Medical Clinics of North America, 2023
Introduced in 2014, genitourinary syndrome of menopause (GSM) describes a variety of unpleasant genital, sexual and urinary symptoms that can either be isolated or coexisting and are not related to other medical conditions. GSM is a chronic and progressive condition that requires early recognition and appropriate management to preserve urogenital ...
Shanice, Cox, Ryan, Nasseri, Rachel S, Rubin, Yahir, Santiago-Lastra   +3 more
openaire   +2 more sources

The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society.

Menopause, 2020
OBJECTIVE To update and expand the 2013 position statement of The North American Menopause Society (NAMS) on the management of the genitourinary syndrome of menopause (GSM), of which symptomatic vulvovaginal atrophy (VVA) is a component.

semanticscholar   +1 more source

Treatment of the genitourinary syndrome of menopause [PDF]

Climacteric, 2015
The vagina, vulva, vestibule, labia majora/minora, and bladder trigone have a high concentration of estrogen receptors; therefore, they are a sensitive biological indicator of serum levels of these hormones in women. The estrogen loss in postmenopausal women produces a dysfunction called genitourinary syndrome of menopause.
José Luis Neyro, Santiago Palacios, A. Mejía   +2 more
openaire   +2 more sources

Genitourinary syndrome of menopause: the unmet need

Menopause, 2021
Abstract Genitourinary syndrome of menopause (GSM) is a highly prevalent and progressive condition of postmenopausal women that has significant negative effects on vulvovaginal health, sexual health, and overall quality of life. Despite many available safe and effective therapies, GSM often goes undiagnosed and untreated.
Susan Kellogg Spadt, Lisa Larkin
openaire   +3 more sources